![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2021
Puelles, J.; Fofana, F.; Rodriguez, D.; Silverberg, J.; Wollenberg, A.; Barbosa, C. Dias; Vernon, M.; Chavda, R.; Gabriel, S. und Piketty, C.
(2021):
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis.
In: British Journal of Dermatology, Bd. 186, Nr. 2: S. 285-294
2020
Barbarot, S.; Wollenberg, A.; Silverberg, J.; Deleuran, M.; Pellacani, G.; Armario-Hita, J. C.; Cheng, Z.; Shumel, B.; Eckert, L.; Gadkari, A.; Lu, Y. und Rossi, A. B.
(2020):
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials.
In: Journal of Dermatological Treatment
Reich, K.; DeLozier, A. M.; Nunes, F. P.; Thyssen, J. P.; Eichenfield, L. F.; Wollenberg, A.; Terres, J. A. Ross; Watts, S. D.; Chen, Y-F; Simpson, E. L. und Silverberg, J.
(2020):
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
In: Journal of Dermatological Treatment